What is Nang Kuang Pharmaceutical Co., Ltd.'s (1752.TW) StockRank?

MoatMap's StockRank for Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) is 62/100, with a Hold signal. This is a composite score combining Quality (56), Value (57), and Momentum (38) factor ranks across MoatMap's 20,000+ stock universe.

Does Nang Kuang Pharmaceutical Co., Ltd. have an economic moat?

Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Nang Kuang Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) is Hold, based on a StockRank of 62/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Nang Kuang Pharmaceutical Co., Ltd. in?

Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (Taiwan).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

1752.TW

HOLDREMOVE

Nang Kuang Pharmaceutical Co., Ltd. · Healthcare · Taiwan · $104M · Avg Vol: $88K/d

StockRank

P/E (TTM)

13.8x

ROE

8.7%

D/E

0.3x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Nang Kuang Pharmaceutical is a Taiwanese manufacturer of sterile generic injections. It lacks the global scale, proprietary technology, and pricing power of high-end CDMOs, and its quality score (Q: 59) is insufficient.

COMPANY DESCRIPTION

Nang Kuang Pharmaceutical Co., Ltd. manufactures sterile generic injectables, pre-filled syringes, and infusion bags. The company is a leading supplier of aseptic injectables in Taiwan, with a growing export footprint in Japan and the United States. It operates as a high-barrier pharmaceutical manufacturer with advanced aseptic production lines and strict regulatory compliance.

FINANCIAL SUMMARY (USD)

Year	2021	2022	2023	2024	2025	CAGR
Revenue	—	61.3M	67.9M	69.5M	68.3M	3.7%
EPS	0.06	0.11	0.06	0.08	—	7.5%
Shares	—	101.0M	101.0M	101.0M	101.0M	-0.0%
Debt	—	12.9M	19.1M	20.2M	20.7M	17.0%
Equity	—	76.2M	75.1M	76.5M	78.5M	1.0%
Op CF	—	11.7M	10.8M	14.7M	14.7M	7.9%
Inv CF	—	-3.5M	-10.4M	-11.8M	-8.9M	—
Fin CF	—	-8.7M	-1.1M	-5.4M	-4.4M	—

PRICE (1Y)-0.8%

SMA 50SMA 200

$1.03

RSI (14)

37.1

52W High

$1.29

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

10.9%75.8

ROE

8.7%68.3

GP/Assets

19.4%45.3

Op. Margin

13.4%72.2

FCF/Assets

-3.2%40.3

Piotroski

782.3

Int. Cover

34.9x74.2

D/E Ratio

0.29x43.8

Current Ratio

1.22x16.3

Value

P/E (TTM)

13.8x76.4

EV/EBITDA

8.3x75.6

P/FCF

—N/A

P/B

1.4x71.9

P/S

1.6x73.5

Div Yield

—N/A

Momentum

52W High %

80%74.9

RS 6M

-79%12.0

SMA 50/200

0.92x41.6

EPS Rev 4W

+0.5%74.5

EPS Rev 12W

—N/A

EPS Improve

—40.8

Q Growth

-55%8.4

FUNDAMENTALS

Market Cap

$104M

P/E (Forward)

10.7x

Gross Margin

34.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 1752.TW are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
1752.TW	Nang Kuang Pharmaceutical Co., Ltd.(you)	$104M	62	HOLD
9103.TW	Medtecs International Corporation Limited	$90M	65	BUY
1565.TWO	St.Shine Optical Co.,Ltd.	$149M	63	HOLD
1783.TW	Maxigen Biotech Inc.	$109M	80	STRONG BUY
6527.TWO	Crystalvue Medical Corporation	$57M	81	STRONG BUY
4126.TWO	Pacific Hospital Supply Co., Ltd	$184M	86	STRONG BUY
1786.TW	SciVision Biotech Inc.	$123M	27	SELL
4737.TW	Bionime Corporation	$140M	25	SELL
6612.TWO	ICARES Medicus, Inc.	$109M	18	STRONG SELL
4771.TW	Vizionfocus Inc.	$357M	87	STRONG BUY

Peer medians: ROE 3.4% · P/E 16.4x · Gross margin 42.1%

Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) — Stock Score Summary

Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) has a MoatMap StockRank of 62/100 based on Quality (56/100), Value (57/100), and Momentum (38/100) factor scores. The current signal is HOLD. Nang Kuang Pharmaceutical is a Taiwanese manufacturer of sterile generic injections. It lacks the global scale, proprietary technology, and pricing power of high-end CDMOs, and its quality score (Q: 59) is insufficient.

Key Financial Metrics

Price	$1.03
Market Cap	$104M
P/E (TTM)	13.84
P/E (Forward)	10.69
Price/Book	1.43
Return on Equity	8.7%
Return on Invested Capital	10.9%
Debt/Equity	29.45
Gross Margin	34.9%
Operating Margin	13.4%
Revenue Growth	-8.6%
Free Cash Flow	$-122K

Nang Kuang Pharmaceutical Co., Ltd. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (Taiwan).

Frequently Asked Questions

What is Nang Kuang Pharmaceutical Co., Ltd.’s (1752.TW) StockRank?: MoatMap’s StockRank for Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) is 62/100, with a Hold signal. It is a composite of Quality (56), Value (57), and Momentum (38) factor ranks across MoatMap’s 20,000+ stock universe.
Does Nang Kuang Pharmaceutical Co., Ltd. have an economic moat?: Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) has a Quality factor score of 56/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Nang Kuang Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) is Hold, based on a StockRank of 62/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Nang Kuang Pharmaceutical Co., Ltd. in?: Nang Kuang Pharmaceutical Co., Ltd. (1752.TW) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (Taiwan).